Axon Enterprise, Inc. (NASDAQ:AXON) Stock Position Reduced by Lazard Asset Management LLC

Lazard Asset Management LLC trimmed its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 42.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 807 shares of the biotechnology company's stock after selling 584 shares during the quarter. Lazard Asset Management LLC's holdings in Axon Enterprise were worth $478,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. LRT Capital Management LLC raised its position in shares of Axon Enterprise by 30.9% during the 4th quarter. LRT Capital Management LLC now owns 855 shares of the biotechnology company's stock worth $508,000 after buying an additional 202 shares in the last quarter. Investment Management Corp of Ontario raised its position in shares of Axon Enterprise by 13.9% during the 4th quarter. Investment Management Corp of Ontario now owns 2,712 shares of the biotechnology company's stock worth $1,612,000 after buying an additional 330 shares in the last quarter. Ground Swell Capital LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth about $322,000. Ellevest Inc. bought a new stake in shares of Axon Enterprise during the 4th quarter worth about $295,000. Finally, Ensign Peak Advisors Inc raised its position in shares of Axon Enterprise by 11.5% during the 4th quarter. Ensign Peak Advisors Inc now owns 32,965 shares of the biotechnology company's stock worth $19,592,000 after buying an additional 3,402 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Matthew R. Mcbrady sold 400 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The shares were sold at an average price of $718.40, for a total transaction of $287,360.00. Following the transaction, the director now directly owns 3,492 shares of the company's stock, valued at approximately $2,508,652.80. The trade was a 10.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 34,969 shares of company stock worth $23,127,314 over the last 90 days. 4.40% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms have commented on AXON. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $652.73.

Axon Enterprise Trading Up 2.0%

Shares of AXON stock traded up $14.71 during trading hours on Tuesday, reaching $746.08. 477,301 shares of the stock traded hands, compared to its average volume of 741,273. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $748.80. The business has a fifty day moving average price of $610.27 and a 200 day moving average price of $607.70. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $58.08 billion, a PE ratio of 192.79, a PEG ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same quarter in the previous year, the business earned $1.15 earnings per share. The firm's revenue was up 31.3% compared to the same quarter last year. On average, equities research analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.